Form 4 for ELAN Elanco Animal Health Inc
Accepted 2025-12-15 00:00:00 ET · period of report 2025-12-11 · accession 0001724169-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | 2025-12-11 | ELAN | VanHimbergen Robert M | EVP, CFO | P - Purchase | $21.64 | +6,950 | 124.2K | +6% | +$150.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | P | A | 6,950 | $21.64 | 124,233 | D | — | — | (F1) Reflects the weighted average price of 6,950 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.60 to $21.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) The balance includes 7,426 shares that were previously reported but inadvertently omitted from the reporting person's balance on his last Form 4. |